PMChek
  • Home
  • Login
  • About Us
  • Contact Us
  • Blog
  • Drug Shortages
PMChek
Drug Shortages
Drug Shortages

Drug Shortages reported to us

Drug Shortages can occur because of manufacturing and quality problems, delays and discontinuations.


Sort By: Date | Name


Drug Shortages

Monday, November 3, 2025

  • FDA Acetaminophen; Oxycodone Hydrochloride Tablet (NDC 60951071270) ENDO USA
  • FDA Acetaminophen; Oxycodone Hydrochloride Tablet (NDC 60951070070) ENDO USA
  • FDA Acetaminophen; Oxycodone Hydrochloride Tablet (NDC 60951060285) ENDO USA
  • FDA Acetaminophen; Oxycodone Hydrochloride Tablet (NDC 60951070170) ENDO USA
  • FDA Acetaminophen; Oxycodone Hydrochloride Tablet (NDC 60951060270) ENDO USA
  • FDA Acetaminophen; Oxycodone Hydrochloride Tablet (NDC 63481062770) ENDO USA
  • FDA Atazanavir Sulfate; Cobicistat Tablet (NDC 00003364111) B-M SQUIBB U.S. (PRIMARY CARE)
  • FDA Everolimus Tablet (NDC 00378000685) MYLAN
  • FDA Everolimus Tablet (NDC 00378000585) MYLAN
  • FDA Everolimus Tablet (NDC 00378000785) MYLAN
  • FDA Lasmiditan Succinate Tablet (NDC 00002449108) LILLY
  • FDA Lasmiditan Succinate Tablet (NDC 00002431208) LILLY
  • FDA Scopolamine Transdermal System (NDC 45802058046) PADAGIS

Friday, October 31, 2025

  • FDA Phenobarbital Tablet (NDC 00603516621) ENDO USA
  • FDA Phenobarbital Tablet (NDC 00603516532) ENDO USA
  • FDA Phenobarbital Tablet (NDC 00603516721) ENDO USA
  • FDA Phenobarbital Tablet (NDC 00603516632) ENDO USA
  • FDA Phenobarbital Tablet (NDC 00603516832) ENDO USA
  • FDA Phenobarbital Tablet (NDC 00603516732) ENDO USA
  • FDA Phenobarbital Tablet (NDC 00603516821) ENDO USA
  • FDA Phenobarbital Tablet (NDC 00603516521) ENDO USA

Thursday, October 30, 2025

  • MFR Simethicone Ultra Strength 180 MG (NDC 00536130608)

Wednesday, October 29, 2025

  • FDA Moxifloxacin Injection (NDC 63323085074) FRESENIUS KABI USA

Monday, October 27, 2025

  • FDA Pramlintide Acetate Injection (NDC 00310662702) ASTRAZENECA
  • FDA Pramlintide Acetate Injection (NDC 00310661502) ASTRAZENECA

Friday, October 24, 2025

  • FDA Busulfan Injection (NDC 67457089308) MYLAN INSTITUTIONAL
  • FDA Insulin Glargine Injection (NDC 00002821405) LILLY
  • FDA Insulin Lispro Injection (NDC 00002821305) LILLY
  • FDA Insulin Lispro-aabc Injection (NDC 00002823505) LILLY
  • FDA Lorazepam Injection (NDC 65219036802) FRESENIUS KABI USA
  • MFR Ciprofloxacin HCl 0.2 % (NDC 42195055014) XSPIRE PHARMA
  • MFR Secura Protective 98.789 % (NDC 50484031500)

Tuesday, October 21, 2025

  • FDA Tranylcypromine Sulfate Tablet (NDC 00591559001) ACTAVIS PHARMA

Monday, October 20, 2025

  • FDA Oxaliplatin Injection (NDC 00781331570) SANDOZ
  • FDA Oxaliplatin Injection (NDC 00781331780) SANDOZ

Friday, October 17, 2025

  • FDA Elbasvir; Grazoprevir Tablet (NDC 00006307402) MERCK SHARP & DOHME

Thursday, October 16, 2025

  • FDA Pemetrexed Disodium Injection (NDC 00002762301) LILLY
  • FDA Pemetrexed Disodium Injection (NDC 00002764001) LILLY
  • FDA Vigabatrin Oral Solution (NDC 80789011750) PYROS PHARMACEUTICALS
  • FDA Voriconazole Injection (NDC 00049319001) NOVAPLUS/PFIZER U.S.

Friday, October 10, 2025

  • FDA Pemetrexed Disodium Injection (NDC 00781351990) SANDOZ
  • FDA Pemetrexed Disodium Injection (NDC 00781351876) SANDOZ

Thursday, October 9, 2025

  • FDA Adalimumab-afzb Injection (NDC 00025032501) PFIZER U.S.
  • FDA Omeprazole Delayed Release Capsule (NDC 00781286892) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781223431) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781223401) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781286801) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781223410) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781286831) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781285931) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781285901) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781286810) SANDOZ
  • FDA Omeprazole Delayed Release Capsule (NDC 00781285910) SANDOZ

Tuesday, October 7, 2025

  • FDA Cobicistat Tablet (NDC 61958140101) GILEAD SCIENCES
  • FDA Paricalcitol Capsule (NDC 00074903630) ABBVIE
  • FDA Paricalcitol Capsule (NDC 00074903730) ABBVIE

Wednesday, October 1, 2025

  • FDA Hydrochlorothiazide; Quinapril Hydrochloride Tablet (NDC 00071521223) PFIZER U.S.
  • FDA Hydrochlorothiazide; Quinapril Hydrochloride Tablet (NDC 00071311223) PFIZER U.S.
  • FDA Quinapril Hydrochloride Tablet (NDC 00071053523) PFIZER U.S.
  • FDA Quinapril Hydrochloride Tablet (NDC 00071052723) PFIZER U.S.
  • FDA Quinapril Hydrochloride Tablet (NDC 00071053023) PFIZER U.S.
  • FDA Quinapril Hydrochloride Tablet (NDC 00071053223) PFIZER U.S.

Tuesday, September 30, 2025

  • FDA Oseltamivir Phosphate Capsule (NDC 00004080185) GENENTECH

Monday, September 29, 2025

  • FDA Fondaparinux Sodium Injection (NDC 00781344395) SANDOZ
  • FDA Fondaparinux Sodium Injection (NDC 00781347695) SANDOZ
  • FDA Fondaparinux Sodium Injection (NDC 00781346595) SANDOZ
  • FDA Fondaparinux Sodium Injection (NDC 00781345495) SANDOZ
  • FDA Tafamidis Meglumine Capsule (NDC 00069197540) PFIZER U.S.
  • FDA Triazolam Tablet (NDC 00009001758) PFIZER U.S.

Friday, September 26, 2025

  • FDA Irinotecan Hydrochloride Injection (NDC 25021023005) SAGENT PHARMACEUTICAL
  • FDA Irinotecan Hydrochloride Injection (NDC 25021023002) SAGENT PHARMACEUTICAL

Friday, September 19, 2025

  • FDA Obeticholic Acid Tablet (NDC 69516000530) INTERCEPT PHARMACEUTICALS
  • FDA Obeticholic Acid Tablet (NDC 69516001030) INTERCEPT PHARMACEUTICALS
  • FDA Pilocarpine Hydrochloride Tablet (NDC 00228283711) ACTAVIS PHARMA
  • FDA Pilocarpine Hydrochloride Tablet (NDC 00228280111) ACTAVIS PHARMA

Thursday, September 18, 2025

  • FDA Desonide Lotion (NDC 00472080302) ACTAVIS MID ATLANTIC
  • FDA Desonide Lotion (NDC 00472080304) ACTAVIS MID ATLANTIC
  • FDA Fluphenazine Hydrochloride Tablet (NDC 00832600311) UPSHER-SMITH
  • FDA Fluphenazine Hydrochloride Tablet (NDC 00832600611) UPSHER-SMITH
  • FDA Fluphenazine Hydrochloride Tablet (NDC 00832600511) UPSHER-SMITH
  • FDA Fluphenazine Hydrochloride Tablet (NDC 00832600411) UPSHER-SMITH

Thursday, September 11, 2025

  • FDA Gemcitabine Hydrochloride Injection (NDC 00409018325) NOVAPLUS/HOSPIRA
  • FDA Gemcitabine Hydrochloride Injection (NDC 00409018225) NOVAPLUS/HOSPIRA
  • FDA Gemcitabine Hydrochloride Injection (NDC 00409018125) NOVAPLUS/HOSPIRA
  • FDA Homatropine Methylbromide and Hydrocodone Bitartrate Syrup (NDC 00472103016) ACTAVIS MID ATLANTIC
  • FDA Oxycodone Hydrochloride Oral Solution (NDC 00054039041) HIKMA PHARMACEUTICALS USA

Tuesday, September 9, 2025

  • FDA Azithromycin Injection (NDC 00409014411) HOSPIRA
  • FDA Vancomycin Hydrochloride Injection (NDC 00409653501) HOSPIRA
  • FDA Vancomycin Hydrochloride Injection (NDC 00409653101) HOSPIRA

Monday, September 8, 2025

  • FDA Sumatriptan Nasal Spray (NDC 66993008269) PRASCO LABORATORIES
  • FDA Sumatriptan Nasal Spray (NDC 66993008169) PRASCO LABORATORIES
  • FDA Vecuronium Bromide Injection (NDC 47335093244) SUN PHARMACEUTICALS

Important:   Items shown in shortage are based on information provided by wholesalers when they list manufacturer out and discontinued items. Items are shown for 60 days from date of initial insertion on this list.

PMChek® | 1306 Oxbridge Dr, Lutz FL 33549
Copyright (C) 2025 PMChek.com
Home, About Us, Contact Us, Privacy